Innovative polatuzumab vedotin plus R-CHP therapy reshapes treatment of older adult patients with diffuse large B-cell lymphoma.

During a live event, Catherine J. Lee, MD, MS, discussed the mechanism of action of approved therapies for chronic ...

With the CSF-1R inhibitor space heating up, Merck KGaA has gone all-in on pimicotinib, paying Abbisko Therapeutics $85 million to secure the global license to the drug.

Very little research has been done on whether a specific brain stimulating activity ... zoom out and consider other factors that may play a role, the experts said. In 2024, the Lancet Commission ...

Filgrastim, a recombinant granulocyte colony-stimulating factor (G-CSF), and sargramostim, a recombinant granulocytemacrophage colony-stimulating factor (GM-CSF), have been available in the United ...

and he still sent his laundry out. When we meet Emelie, the sometime narrator of Annika Norlin’s debut novel, “The Colony,” she’s already gone full Thoreau. Modern city life — “the ...